Effect of danazol on vocal pitch: a case study
Acoustic analysis of a woman undergoing danazol therapy for endometriosis revealed a progressive and persistent lowering of vocal pitch that did not fully return to pretreatment levels 12 months after treatment.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This case study investigates the impact of danazol, a synthetic androgen, on vocal pitch in a single subject. The researchers measured changes in voice characteristics following the administration of the drug to assess potential side effects on the larynx. The findings indicate that danazol treatment can lead to significant lowering of vocal pitch due to its androgenic properties. This paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
950 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (3)
Cited by (3)
Source provenance
- europepmc
- last seen: 2026-10-15T06:08:49.021275+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-10-08T21:47:03.166880+00:00